Skip to content
EVOHN

Stack 01

Regenerative Protocol

Angiogenic signalling, cytoskeletal mobilisation and matrix synthesis in one preparation.

Research domain
Recovery
Components
02
Certification
Per component
Supply
Never pre-mixed
EVOHN BPC-157 + TB-500
EVOHN GHK-Cu

Overview

What this grouping is

The most frequently assembled grouping in the tissue-repair literature. BPC-157, TB-500 and GHK-Cu act on three different stages of the same process — vascular supply, cell migration, and the matrix those cells deposit — which is why comparative work rarely examines one without reference to the others.

Assembled here as independently certified vials rather than a blend, so that a component can be withheld, substituted or titrated without discarding the group. Each vial carries its own analytical record.

Purpose

To make the three principal mechanisms of soft-tissue remodelling available in one documented set, so that their contributions can be separated rather than confounded.

Included peptides

02 independently certified vials

Each component carries its own batch number and its own certificate of analysis. A stack result is only traceable if every batch identifier is recorded.

  • 01

    BPC-157 + TB-500

    5 mg + 5 mg / vial

    Angiogenic signalling and actin sequestration — establishes vascular supply and mobilises the cellular response.

    Assayed purity99.82%
    98%Spec ≥ 99%100%
  • 02

    GHK-Cu

    50 mg / vial

    Copper delivery and matrix regulation — governs what is deposited.

    Assayed purity99.68%
    98%Spec ≥ 99%100%

Scientific summary

BPC-157 is characterised as acting on the VEGFR2-Akt-eNOS axis, establishing vascular supply. TB-500 sequesters monomeric G-actin and shifts the polymerisation equilibrium that governs cell migration into the affected region. GHK-Cu delivers copper to fibroblasts and modulates the balance between matrix metalloproteinases and their tissue inhibitors, determining what those migrated cells deposit. The published rationale for the grouping is sequential rather than additive: each mechanism is upstream of the next.

Ideal research use

  • 01Soft-tissue and connective-tissue repair models
  • 02Comparative studies isolating angiogenic from cytoskeletal contribution
  • 03Dermal preparations where matrix deposition is the measured endpoint
  • 04Method development requiring a well-characterised positive control set

Protocol information

How the set is handled

A description of laboratory practice as the published record reports it. Nothing here is administration guidance, and none of it should be read as such.

  1. 01Sequencing in the literaturePublished designs commonly stagger introduction rather than combining from the outset, so that the angiogenic and cytoskeletal contributions can be resolved separately in the time course.
  2. 02ReconstitutionEach component is reconstituted independently in bacteriostatic water. GHK-Cu is prepared last where both are handled in one session, because the copper complex is the most oxidation-sensitive of the group.
  3. 03Preparation orderDiluent is introduced against the vial wall and the vial swirled, never shaken. TB-500 and BPC-157 tolerate standard handling; GHK-Cu should be prepared with minimal headspace.
  4. 04DocumentationRecord the batch number of each component separately. Because the vials are not pre-mixed, a group result is only traceable if every batch identifier in the set is captured.

Storage

Every component is supplied lyophilised and is stored independently at −20 °C, protected from light and moisture. Components are not pre-mixed: each vial carries its own batch number and its own certificate of analysis, and each is reconstituted separately. Once in solution, hold at 2–8 °C and observe the interval stated on the batch certificate for that specific component — the shortest interval in the group governs the group.

Storage & handling guide

Frequently asked

About this grouping

This catalogue is presented for informational purposes only. It is not an offer of sale, and it makes no medical or therapeutic claim.

Enquiries

Discuss the protocol.

Ask a specialist about the Regenerative Protocol — component batches, current documentation, and what can be supplied to your territory.